echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > What trends in drug research and development does the FDA's approval of new drug standards represent in the past five years?

    What trends in drug research and development does the FDA's approval of new drug standards represent in the past five years?

    • Last Update: 2021-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Author: small two

    As we all know, the U.


    As the vane of global drug regulatory agencies, the FDA has always been known for its high standards.


    This article mainly introduces the FDA approved new drug model that has been sought after in China in recent years and the trend of new drug approval under the FDA's high standards.


    505(b)(2)

    505(b)(2)

    In 1984, the U.


    The 505(b)(2) application contains a complete safety and effectiveness research report, but at least part of the information comes from research conducted by non-applicants or that the applicant has no right to cite.


    Data source: Yaozhi data; Yaozhi consulting and collation

    In addition to the reduction in the number of approvals that may be caused by the impact of COVID-19 in 2020, the number of 505(b)(2) notifications has increased year by year in recent years.


    It is worth noting that: in December 2019, the innovative drug levalamlodipine maleate tablets (trade name: CONJUPRI) independently developed by Sinopharm Group Ouyi Pharmaceutical Co.


    CONJUPRI is a calcium channel blocker used to treat high blood pressure.


    First in Class

    First in Class

    First in Class is the first innovative drug, which can be indirectly understood as 505(b)(1).


    Industry insiders have pointed out: "The essence of First in Clas is to take a road that has not been walked or passed by the predecessors.


    Data source: Yaozhi data; Yaozhi consulting and collation

    In 2020, some of the more representative first drugs such as Rukobia (fostemsavir) tablets, a new type of antiretroviral drug, are suitable for adults with HIV-1, and have tried multiple HIV before.


    Rukobia's approval marks a new class of antiretroviral drugs that may benefit patients who have exhausted other HIV-1 treatment options.


    1st US

    1st US

    1st US is Approval in the US Before Other Countries.


    Data source: Yaozhi data; Yaozhi consulting and collation

    FDA base drug

    FDA base drug

    On August 6, 2020, the then President of the United States issued an executive order "on ensuring that essential medicines and medical countermeasures are produced in the United States".


    FDA base drugs are the drugs most needed by patients in emergency medical institutions in the United States.


    Data source: Yaozhi data, Yaozhi consultation and collation; Drugs@FDA

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.